PubRank

David Eidelberg

Author PubWeight™ 145.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007 7.01
2 Network modulation in the treatment of Parkinson's disease. Brain 2006 2.52
3 Changes in network activity with the progression of Parkinson's disease. Brain 2007 2.46
4 Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2006 2.42
5 Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009 2.01
6 Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A 2007 1.98
7 Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2006 1.92
8 Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 2006 1.84
9 A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput 2005 1.78
10 Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study. J Neurophysiol 2003 1.71
11 Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol 2003 1.63
12 Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 2008 1.56
13 Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 2010 1.56
14 The differential effect of PD and normal aging on early explicit sequence learning. Neurology 2003 1.52
15 Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 2010 1.50
16 Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord 2008 1.44
17 Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage 2010 1.43
18 Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases. J Neurosurg 2011 1.43
19 Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007 1.42
20 Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008 1.39
21 Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002 1.39
22 Microstructural white matter changes in primary torsion dystonia. Mov Disord 2008 1.38
23 Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2010 1.36
24 Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 2006 1.36
25 Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 2009 1.36
26 Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol 2002 1.35
27 Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol Dis 2010 1.34
28 Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A 2011 1.33
29 Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain 2007 1.33
30 Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol 2012 1.32
31 Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. Clin Positron Imaging 1998 1.31
32 Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med 2002 1.31
33 Imaging essential tremor. Mov Disord 2010 1.27
34 Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 2004 1.26
35 Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab 2006 1.26
36 Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol 2004 1.24
37 Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 2008 1.24
38 Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 2006 1.24
39 Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp 2003 1.23
40 Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 2004 1.21
41 Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 2004 1.21
42 Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 2009 1.20
43 Neuroimaging and therapeutics in movement disorders. NeuroRx 2005 1.17
44 Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. Brain 2010 1.16
45 The metabolic topography of posthypoxic myoclonus. Neurology 2004 1.16
46 The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry 2009 1.16
47 An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol 2006 1.15
48 Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage 2011 1.15
49 Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci 2008 1.15
50 The metabolic pathology of dopa-responsive dystonia. Ann Neurol 2005 1.14
51 Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 2010 1.14
52 Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage 2008 1.12
53 Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 2002 1.12
54 L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease. Parkinsonism Relat Disord 2006 1.08
55 Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 2002 1.06
56 Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 2007 1.06
57 Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol 2007 1.03
58 Functional brain imaging in Parkinson's disease. Adv Neurol 2003 1.03
59 Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) 2008 1.02
60 Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis 2008 1.02
61 Functional imaging of sequence learning in Parkinson's disease. J Neurol Sci 2006 1.01
62 Early Parkinson's disease: longitudinal changes in brain activity during sequence learning. Neurobiol Dis 2009 1.00
63 Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study. Neuroimage 2006 1.00
64 Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab 2011 0.99
65 Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry 2002 0.99
66 Metabolic changes in DYT11 myoclonus-dystonia. Neurology 2013 0.98
67 Identification of disease-related spatial covariance patterns using neuroimaging data. J Vis Exp 2013 0.98
68 Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. J Nucl Med 2003 0.98
69 Metabolic network as a progression biomarker of premanifest Huntington's disease. J Clin Invest 2013 0.95
70 Impaired sequence learning in dystonia mutation carriers: a genotypic effect. Brain 2011 0.95
71 Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg 2003 0.95
72 Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 2009 0.94
73 Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage 2004 0.93
74 Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging 2004 0.93
75 Neuroimaging in human dystonia. J Med Invest 2005 0.93
76 Parkinson's disease: increased motor network activity in the absence of movement. J Neurosci 2013 0.93
77 Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners. Hum Brain Mapp 2013 0.92
78 Functional brain networks in movement disorders: recent advances. Curr Opin Neurol 2012 0.92
79 Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol Aging 2006 0.92
80 Pallidal stimulation for parkinsonism: improved brain activation during sequence learning. Ann Neurol 2002 0.92
81 Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning. Hum Brain Mapp 2003 0.92
82 Abnormal metabolic network activity in REM sleep behavior disorder. Neurology 2014 0.91
83 Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain 2009 0.91
84 Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 2007 0.91
85 Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Hum Brain Mapp 2010 0.91
86 Parkinson's disease cognitive network correlates with caudate dopamine. Neuroimage 2013 0.91
87 Abnormal brain networks in primary torsion dystonia. Adv Neurol 2004 0.91
88 Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011 0.90
89 Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET. J Neurosurg 2009 0.90
90 Network modulation following sham surgery in Parkinson's disease. J Clin Invest 2014 0.89
91 Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography. Curr Opin Neurol 2002 0.89
92 Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation. J Neurosci 2012 0.89
93 FDG PET in the Evaluation of Parkinson's Disease. PET Clin 2010 0.87
94 Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow. J Cereb Blood Flow Metab 2011 0.85
95 Increased reaction time predicts visual learning deficits in Parkinson's disease. Mov Disord 2010 0.85
96 Testing a test for Alzheimer disease. Neurology 2007 0.85
97 Three-fold cross-validation of parkinsonian brain patterns. Conf Proc IEEE Eng Med Biol Soc 2010 0.85
98 Gene transfer therapy for neurodegenerative disorders. Mov Disord 2007 0.84
99 Seizure propagation in a patient with musicogenic epilepsy. Epilepsy Behav 2008 0.83
100 To scan or not to scan: DaT is the question. Neurology 2012 0.83
101 Early registration of diffusion tensor images for group tractography of dystonia patients. J Magn Reson Imaging 2012 0.83
102 The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy. Clin Auton Res 2004 0.82
103 Functional brain imaging of cognitive dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 2012 0.82
104 Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders. Curr Opin Neurol 2003 0.81
105 Understanding the anatomy of dystonia: determinants of penetrance and phenotype. Curr Neurol Neurosci Rep 2013 0.81
106 Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study. J Cereb Blood Flow Metab 2013 0.81
107 Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside. Prog Brain Res 2010 0.81
108 The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome. Am J Geriatr Psychiatry 2011 0.80
109 Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease. Mov Disord 2006 0.80
110 Abnormal network topographies and changes in global activity: absence of a causal relationship. Neuroimage 2012 0.80
111 Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse 2009 0.80
112 Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Mov Disord 2009 0.79
113 Dopamine cell transplantation in Parkinson's disease: challenge and perspective. Br Med Bull 2011 0.79
114 Serotonin modulation of cerebral glucose metabolism: sex and age effects. Synapse 2012 0.78
115 Preoperative response to levodopa is the best predictor of transplant outcome. Ann Neurol 2004 0.78
116 Functional neuroimaging in Parkinson's disease. Cold Spring Harb Perspect Med 2012 0.77
117 Basal ganglia and kinematics modulation: insights from Parkinson's and Huntington's diseases. Parkinsonism Relat Disord 2011 0.77
118 Re-emergent tremor without accompanying rest tremor in Parkinson's disease. Can J Neurol Sci 2008 0.77
119 Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity. Mov Disord 2003 0.77
120 White matter changes in primary dystonia determined by 2D distribution analysis of diffusion tensor images. J Magn Reson Imaging 2012 0.76
121 Milestones in neuroimaging. Mov Disord 2011 0.76
122 New strategies for automated differential diagnosis of degenerative brain disorders. Conf Proc IEEE Eng Med Biol Soc 2007 0.76
123 Assessment of disease progression in parkinsonism. J Neurol 2004 0.76
124 Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging. Int J Geriatr Psychiatry 2012 0.76
125 Can imaging distinguish PSP from other neurodegenerative disorders? Neurology 2002 0.75
126 Different β-amyloid binding patterns in Alzheimer and Parkinson diseases: it's the network! Neurology 2013 0.75
127 Effects of levodopa on regional cerebral metabolism and blood flow. Mov Disord 2014 0.75
128 Mom and me: brain metabolism links Alzheimer disease to maternal genes. Neurology 2009 0.75
129 Brain stimulation and functional imaging with fMRI and PET. Handb Clin Neurol 2013 0.75
130 Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease. Neurosci Bull 2014 0.75
131 Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder. J Cereb Blood Flow Metab 2015 0.75
132 Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes. Mov Disord 2004 0.75
133 Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET. Nucl Med Biol 2004 0.75
134 Correlation of laparoscopic experience with differential functional brain activation: a positron emission tomography study with oxygen 15-labeled water. Arch Surg 2012 0.75
135 Positron emission tomography imaging. Front Neurol Neurosci 2009 0.75